Table II.
Characteristics of the study sample from mouse.
| Patient | Status | Week after infection | Cell type | Proviral DNA loads per 100 PBMCs |
|---|---|---|---|---|
| Case 11 | Uninfected | – | PBMC | – |
| Case 12 | Uninfected | – | PBMC | – |
| Case 13 | Uninfected | – | PBMC | – |
| Case 14 | Uninfected | – | PBMC | – |
| Case 15 | Uninfected | – | PBMC | – |
| Case 16 | HTLV-1 infected | 7 | PBMC, splenocyte | 97.7 |
| Case 17 | HTLV-1 infected | 5 | PBMC, splenocyte | 99.4 |
| Case 18 | HTLV-1 infected | 9 | PBMC, splenocyte | 75.3 |
| Case 19 | HTLV-1 infected | 9 | PBMC, splenocyte | 76.8 |
| Case 20 | HTLV-1 infected | 5 | PBMC, splenocyte | 96.7 |
HTLV-1, human T-cell leukemia virus type 1; PBMC, peripheral blood mononuclear cell.